Cryoport, Inc. (CYRX) Form 8-K Material Events
Cryoport, Inc. (CYRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CYRX
CIK: 1124524
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerBrian Whisnant
Audit LocationNashville, Tennessee, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001011438-26-000542 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000895421-26-000261 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-11 | OWNERSHIP DOCUMENT | 0001104659-26-094228 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001950047-26-007965 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001104659-26-092107 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | FORM 8-K | 0001104659-26-092064 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-29 | — | SCHEDULE 13G/A Filing | 0001104659-26-088284 | View SEC Doc Filr Page |
| S-8 | 2026-06-22 | — | FORM S-8 | 0001104659-26-076480 | View SEC Doc Filr Page |
| 15-12G | 2026-06-22 | — | 15-12G | 0001104659-26-076482 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | OWNERSHIP DOCUMENT | 0001104659-26-073630 | View SEC Doc Filr Page |
| 144 | 2026-06-11 | — | 144 Filing | 0001950047-26-005914 | View SEC Doc Filr Page |
| 144 | 2026-06-10 | — | 144 Filing | 0001950047-26-005868 | View SEC Doc Filr Page |
| 8-K | 2026-06-09 | 2026-06-05 | FORM 8-K | 0001104659-26-071892 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | OWNERSHIP DOCUMENT | 0001104659-26-071724 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-04 | OWNERSHIP DOCUMENT | 0001104659-26-071509 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | OWNERSHIP DOCUMENT | 0001104659-26-071508 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | OWNERSHIP DOCUMENT | 0001104659-26-071507 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | OWNERSHIP DOCUMENT | 0001104659-26-071506 | View SEC Doc Filr Page |
| 144 | 2026-06-08 | — | 144 Filing | 0001950047-26-005741 | View SEC Doc Filr Page |
| 144 | 2026-06-03 | — | 144 Filing | 0001973097-26-000017 | View SEC Doc Filr Page |
| SD | 2026-05-29 | — | FORM SD | 0001104659-26-068364 | View SEC Doc Filr Page |
| 10-Q | 2026-05-05 | 2026-03-31 | 10-Q | 0001104659-26-055513 | View SEC Doc Filr Page |
| 8-K | 2026-05-04 | 2026-05-04 | FORM 8-K | 0001104659-26-054942 | View SEC Doc Filr Page |
| 4 | 2026-04-23 | 2026-04-21 | OWNERSHIP DOCUMENT | 0001104659-26-047945 | View SEC Doc Filr Page |
| ARS | 2026-04-22 | 2025-12-31 | ARS | 0001140361-26-016133 | View SEC Doc Filr Page |